John E. Davis - 23 Feb 2024 Form 4/A Insider Report for ARTIVION, INC. (AORT)

Role: Chief Commercial Officer
Signature: /s/ John E. Davis
Issuer symbol: AORT
Transactions as of: 23 Feb 2024
Net transactions value: -$70,158
Form type: 4/A
Filing time: 14 Mar 2024, 20:27:15 UTC
Date Of Original Report: 28 Feb 2024
Previous filing: 22 Feb 2024
Next filing: 29 Feb 2024
SEC: View on sec.gov

Key filing fact

John E. Davis filed Form 4/A for ARTIVION, INC. (AORT) on 14 Mar 2024.

Key facts

This page summarizes John E. Davis's Form 4/A filing for ARTIVION, INC. (AORT).
4 reported transactions and 0 derivative rows are listed below.
Filing timestamp: 14 Mar 2024, 20:27.

Change

Previous filing in this sequence was filed on 22 Feb 2024.
Current net transaction value: -$70,158.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A disclosures.

See Original Filing

Transactions Table

AORT transaction

Common Stock

Award

Transaction value: $0
Shares: +5,386
Change %: +3.6%
Price: $0.000000
Shares after: 153,279
Date: 23 Feb 2024
Ownership: Direct
Footnotes: F1

AORT transaction

Common Stock

Sale

Transaction value: $32,150
Shares: -1,586
Change %: -1%
Price: $20.27
Shares after: 151,711
Date: 26 Feb 2024
Ownership: Direct
Footnotes: F2, F3

AORT transaction

Common Stock

Award

Transaction value: $0
Shares: +12,736
Change %: +8.4%
Price: $0.000000
Shares after: 164,447
Date: 23 Feb 2024
Ownership: Direct
Footnotes: F3, F4

AORT transaction

Common Stock

Sale

Transaction value: $38,008
Shares: -1,875
Change %: -1.1%
Price: $20.27
Shares after: 162,572
Date: 26 Feb 2024
Ownership: Direct
Footnotes: F3, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024.
F2	These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,610 shares were sold, when in fact, 1,586 shares were sold.
F3	As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4.
F4	Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date.
F5	These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,904 shares were sold, when in fact, 1,875 shares were sold.